References
- Holmes AH, Moore LS, Sundsfjord A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387:176–187.
- WHO World Health Organization. Critically important antimicrobials for human medicine: ranking of antimicrobial agents for risk management of antimicrobial resistance due to non-human use. 5th revision. Geneva: World Health Organization; 2016. Retrieved from http://apps.who.int/iris/bitstream/10665/255027/1/9789241512220-eng.pdf?ua=1
- Finley RL, Collignon P, Larsson J, et al. The scourge of antibiotic resistance: the important role of the environment. Clin Infect Dis. 2013;57:704–710.
- Buhl M, Peter S, Willmann M. Prevalence and risk factors associated with colonization and infection of extensively drug-resistant Pseudomonas aeruginosa: a systematic review. Expert Rev Anti Infect Ther. 2015;13:1159–1170.
- Brown ED, Wright GD. Antibacterial drug discovery in the resistance era. Nature. 2016;529:336–343.
- Tu Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med. 2011;17:1217–1220.
- Carson CF, Hammer KA, Riley TV. Melaleuca alternifolia (Tea Tree) oil: a review of antimicrobial and other medicinal properties. Clin Microbiol Rev. 2006;19:50–62.
- Juan C, Peña C, Oliver A. Host and pathogen biomarkers for severe Pseudomonas aeruginosa infections. J Infect Dis. 2017;215:S44–S51.
- Tissot F, Blanc DS, Basset P, et al. New genotyping method discovers sustained nosocomial Pseudomonas aeruginosa outbreak in an intensive care burn unit. J Hosp Infect. 2016;94:2–7.
- Stefani S, Campana S, Cariani L, et al. Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis. Int J Med Micro. 2017;307:353–362.
- Vanneste JL. The scientific, economic, and social impacts of the New Zealand outbreak of bacterial canker of kiwifruit (Pseudomonas syringae pv. actinidiae). Ann Rev Phytopathol. 2017;55:377–399.
- Streeter K, Katouli M. Pseudomonas aeruginosa: a review of their pathogenesis and prevalence in clinical settings and the environment. Infect Epidemiol Microbiol. 2016;2:25–32.
- Bonnemain B. Helix and drugs: snails for western health care from antiquity to the present. J Evid Based Complementary Altern Med. 2005;2:25–28.
- Greistorfer S, Klepal W, Cyran N, et al. Snail mucus − glandular origin and composition in Helix pomatia. Zoology. 2017;122:126–138.
- Pietrzyk A, Bujacz A, Mak P, et al. Structural studies of Helix aspersa agglutinin complexed with GalNAc: a lectin that serves as a diagnostic tool. Int J Biol Macromol. 2015;81:1059–1068.
- Mazzulla S, Anile D, De Sio S, et al. In vivo evaluations of emulsion o/w for a new topical anti-aging formulation: short-term and long-term efficacy. J Cosmet Dermatol Sci Appl. 2018;8:110–125.
- Alogna A. New frontiers in snail mucus studies for cosmetic and pharmaceutical preparations. Cosmetiscope. 2017;23:1–6.
- Tsoutsos D, Kakagia D, Tamparopoulos K. The efficacy of Helix aspersa Müller extract in the healing of partial thickness burns: a novel treatment for open burn management protocols. J Dermatolog Treat. 2009;20:219–222.
- Ellijimi C, Hammouda M, Othman H, et al. Helix aspersa maxima mucus exhibits antimelanogenic and antitumoral effects against melanoma cells. Biomed Pharmacother. 2018;101:871–880.
- Cilia G, Fratini F. Antimicrobial properties of terrestrial snail and slug mucus. J Complement Integr Med. 2018. DOI:10.1515/jcim-2017-0168
- Iguchi SM, Takashi A, Matsumoto JJ. Antibacterial activity of snail mucus mucin. Comp Biochem Physiol A Comp Physiol. 1982;72:571–574.
- Kubota Y, Watanabe Y, Otsuka H, et al. Purification and characterization of an antibacterial factor from snail mucus. Comp Biochem Physiol C Comp Pharamacol. 1985;82:345–348.
- Otsuka-Fuchino H, Watanabe Y, Hirakawa C, et al. Bactericidal action of a glycoprotein from the body surface of Giant African Land Snail. Comp Biochem Physiol C Comp Pharamacol. 1992;101:607–613.
- Zhong J, Wang W, Yang X, et al. A novel cysteine-rich antimicrobial peptide from the mucus of the snail of Achatina fulica. Peptides. 2013;39:1–5.
- Pitt SJ, Graham MA, Dedi CG, et al. Antimicrobial properties of mucus from the brown garden snail Helix aspersa. Br J Biomed Sci. 2015;72:174–181.
- Bortolotti D, Trapella C, Bernardi T, et al. Letter to the editor: antimicrobial properties of mucus from the brown garden snail Helix aspersa. Br J Biomed Sci. 2016;73:49–50.
- De Soyza A, Hall AJ, Mahenthiralingam E, et al. Developing an international Pseudomonas aeruginosa reference panel. Microbiologyopen. 2013;2:1010–1023.
- Gorbushin AM, Borisova EA. Lectin-like molecules in transcriptome of littorina littorea hemocytes. Dev Comp Immunol. 2015;48:210–220.
- Gerdol M. Immune-related genes in gastropods and bivalves: a comparative overview. Invert Surviv J. 2017;14:95–110.
- Trapella C, Rizzo R, Gallo S, et al. HelixComplex snail mucus exhibits pro-survival, proliferative and pro-migration effects on mammalian fibroblasts. Sci Rep. 2018;8. DOI:10.1038/s41598-018-35816-3.
- Hanington PC, Zhang SM. The primary role of fibrinogen-related proteins in invertebrates is defense, not coagulation. J Innate Immun. 2011;3:17–27.
- Wang XW, Wang JX. Diversity and multiple functions of lectins in shrimp immunity. Dev Comp Immunol. 2013;39:27–38.
- Fan C, Zhang S, Li L, et al. Fibrinogen-related protein from amphioxus branchiostoma belcheri is a multivalent pattern recognition receptor with a bacteriolytic activity. Mol Immunol. 2008;45:3338–3346.
- Burton MF, Steel PG. The chemistry and biology of LL-37. Nat Prod Rep. 2009;26:1572–1584.
- Kasus‐Jacobi A, Noor‐Mohammadi S, Griffith GL, et al. A multifunctional peptide based on the neutrophil immune defense molecule, CAP37, has antibacterial and wound‐healing properties. J Leukoc Biol. 2015;9:341–350.
- Abdillahi SM, Maaß T, Kasetty G, et al. Collagen VI contains multiple host defense peptides with potent in vivo activity. J Immun. 2018;201:1007–1020.
- Jander G, Rahme LG, Ausubel FM. Positive correlation between virulence of Pseudomonas aeruginosa mutants in mice and insects. J Bacteriol. 2000;182:3843–3845.
- Langan KM, Kotsimbos T, Peleg AY. Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis. Curr Opin Infect Dis. 2015;28:547–556.
- Bayne CJ. Molluscan immunity: induction of elevated immunity in the land snail (Helix) by injections of bacteria (Pseudomonas aeruginosa). Dev Comp Immunol. 1980;4:43–54.